Altimmune SG&A Expense (Quarterly) Insights

Altimmune Inc (ALT)

7.36 +0.06 (+0.82%) USD | NASDAQ | May 06, 16:00

7.30 -0.06 (-0.82%) Pre-Market: 08:32

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2005. Upgrade now.

Date	Value
December 31, 2023	4.332M
September 30, 2023	4.514M
June 30, 2023	4.76M
March 31, 2023	4.531M
December 31, 2022	3.805M
September 30, 2022	4.492M
June 30, 2022	4.41M
March 31, 2022	4.427M
December 31, 2021	3.777M
September 30, 2021	4.156M
June 30, 2021	3.659M
March 31, 2021	3.821M
December 31, 2020	4.112M
September 30, 2020	4.220M
June 30, 2020	2.545M
March 31, 2020	2.332M
December 31, 2019	2.015M
September 30, 2019	2.188M
June 30, 2019	2.232M
March 31, 2019	2.066M
December 31, 2018	2.420M
September 30, 2018	1.964M
June 30, 2018	2.934M
March 31, 2018	2.448M
December 31, 2017	1.594M

Date	Value
September 30, 2017	3.039M
June 30, 2017	1.794M
March 31, 2017	2.030M
December 31, 2016	1.805M
September 30, 2016	3.290M
June 30, 2016	0.9666M
March 31, 2016	1.193M
December 31, 2015	0.9758M
September 30, 2015	1.231M
June 30, 2015	1.819M
March 31, 2015	2.196M
December 31, 2014	2.622M
September 30, 2014	3.192M
June 30, 2014	2.420M
March 31, 2014	2.678M
December 31, 2013	4.580M
September 30, 2013	4.086M
June 30, 2013	2.333M
March 31, 2013	2.280M
December 31, 2012	2.625M
September 30, 2012	3.275M
June 30, 2012	2.780M
March 31, 2012	2.948M
December 31, 2011	2.679M
September 30, 2011	3.283M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

2.015M

Minimum

Dec 2019

4.76M

Maximum

Jun 2023

3.702M

Average

4.112M

Median

Dec 2020

SG&A Expense (Quarterly) Benchmarks